Clinical Trial Update: Early Feasibility Study of the Supira System in Patients Undergoing HRPCI [NA]

View source ↗

Summary

The early feasibility study of the Supira System in patients undergoing high-risk percutaneous coronary intervention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• SUpira System

Snippet

Sponsor: Supira Medical | Conditions: Coronary Artery Disease, High-risk Percutaneous Coronary Intervention | NA | Status: COMPLETED